Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-09-30

Clinical Trial Update: Evaluating the Efficacy and Safety of Vardenafil in Patients Erectile Dysfunction Solely Secondary to Spinal Cord Injury [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating efficacy and safety of vardenafil for erectile dysfunction due to spinal cord injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vardenafil (vardenafil)

Snippet

Sponsor: Bayer | Conditions: Erectile Dysfunction | Phase 3 | Status: COMPLETED